DZHK Paper of the month

With the Paper of the month the Board of Directors rewards a recent scientific publication of DZHK researchers.

November 2014

Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation, doi: 10.1172/JCI74349, (DZHK-Authors: Ahles, Dendorfer, Engelhardt)

Read more

October 2014

Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry, doi: 10.1016/j.jacc.2014.05.049, (DZHK-Autoren: Bernlochner, Schulz, Morath, Schunkert, Laugwitz, Kastrati, Sibbing)

Read more

September 2014

Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling, PNAS, doi: 10.1073/pnas.1409026111, (DZHK-Authors: Lehmann, Spiger, Wieland, Katus, Backs)

Read more

August 2014

The Cardiac CaMKII Genes Delta and Gamma Contribute Redundantly to Adverse Remodeling but Inhibit Calcineurin-Induced Myocardial Hypertrophy, Circulation, doi:10.1161/CIRCULATIONAHA.114.006185 (DZHK authors: Lehmann, Hoting, Maier, Katus, Backs)

Read more

July 2014

Silencing of CCR2 in myocarditis, European Heart Journal, doi:10.1093/eurheartj/ehu225 (DZHK-Autoren: Leuschner, Meder, Katus)

Read more

June 2014

The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages, Nature Communications (2014), doi:10.1038/ncomms4944 (DZHK authors: Müller-Fielitz, Offermanns, Schwaninger)

Read more

May 2014

Dichloroacetate prevents restenosis in preclinical animal models of vessel injury, Nature (2014), doi:10.1038/nature13232 (DZHK authors: Deuse, Zeller, Eschenhagen, Blankenberg, Reichenspurner, Schrepfer)

Read more

April 2014

Assessment of microRNAs in patients with unstable angina pectoris, European Heart Journal, doi: 10.1093/eurheartj/ehu151, (DZHK-authors: Zeller, Keller, Wild, Münzel, Blankenberg)

Read more

March 2014

MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1, Nature Medicine 2014, doi:10.1038/nm.3487, (DZHK-authors: Schober, Weber)

Read more

February 2014

Disruption of Vascular Ca2+-Activated Chloride Currents Lowers Blood Pressure. The Journal of clinical investigation 124, 675-686, (2014) (DZHK-authors: Seniuk, Ehmke)

Read more